Next Article in Journal
Energy Dense Salty Food Consumption Frequency Is Associated with Diastolic Hypertension in Spanish Children
Next Article in Special Issue
Nutrition and Fitness: Mental Health
Previous Article in Journal
Adherence to the Mediterranean Diet in Spanish Population and Its Relationship with Early Vascular Aging according to Sex and Age: EVA Study
Previous Article in Special Issue
Quality of Life and Physical Performance in Patients with Obesity: A Network Analysis

Microbiota-Orientated Treatments for Major Depression and Schizophrenia

Hôpitaux Universitaires de Marseille, Department de Psychiatrie universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, 27 Boulevard Jean Moulin, 13005 Marseille, France
Aix Marseille University, Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infection, Assistance Publique Hôpitaux de Marseille, Institut Hospitalo Universitaire Méditerranée Infection, 13005 Marseille, France
CHU de Clermont-Ferrand, F-63000 Cllermont-Ferrand, France
Aix-Marseille Université, CNRS, Ecole Centrale de Marseille, UMR 7249, Institut Fresnel, Département de médecine nucléaire, CERIMED, Aix-Marseille Université, F-13005 Marseille, France
Author to whom correspondence should be addressed.
Nutrients 2020, 12(4), 1024;
Received: 7 February 2020 / Revised: 31 March 2020 / Accepted: 2 April 2020 / Published: 8 April 2020
(This article belongs to the Special Issue Nutrition and Fitness: Mental Health)
Background and significance. There is a need to develop new hypothesis-driven treatment for both both major depression (MD) and schizophrenia in which the risk of depression is 5 times higher than the general population. Major depression has been also associated with poor illness outcomes including pain, metabolic disturbances, and less adherence. Conventional antidepressants are partly effective, and 44% of the subjects remain unremitted under treatment. Improving MD treatment efficacy is thus needed to improve the SZ prognosis. Microbiota-orientated treatments are currently one of the most promising tracks. Method. This work is a systematic review synthetizing data of arguments to develop microbiota-orientated treatments (including fecal microbiota transplantation (FMT)) in major depression and schizophrenia. Results. The effectiveness of probiotic administration in MD constitutes a strong evidence for developing microbiota-orientated treatments. Probiotics have yielded medium-to-large significant effects on depressive symptoms, but it is still unclear if the effect is maintained following probiotic discontinuation. Several factors may limit MD improvement when using probiotics, including the small number of bacterial strains administered in probiotic complementary agents, as well as the presence of a disturbed gut microbiota that probably limits the probiotics’ impact. FMT is a safe technique enabling to improve microbiota in several gut disorders. The benefit/risk ratio of FMT has been discussed and has been recently improved by capsule administration. Conclusion. Cleaning up the gut microbiota by transplanting a totally new human gut microbiota in one shot, which is referred to as FMT, is likely to strongly improve the efficacy of microbiota-orientated treatments in MD and schizophrenia and maintain the effect over time. This hypothesis should be tested in future clinical trials. View Full-Text
Keywords: psychiatry; schizophrenia; depression; microbiota; transplantation psychiatry; schizophrenia; depression; microbiota; transplantation
Show Figures

Figure 1

MDPI and ACS Style

Fond, G.B.; Lagier, J.-C.; Honore, S.; Lancon, C.; Korchia, T.; Verville, P.-L.S.D.; Llorca, P.-M.; Auquier, P.; Guedj, E.; Boyer, L. Microbiota-Orientated Treatments for Major Depression and Schizophrenia. Nutrients 2020, 12, 1024.

AMA Style

Fond GB, Lagier J-C, Honore S, Lancon C, Korchia T, Verville P-LSD, Llorca P-M, Auquier P, Guedj E, Boyer L. Microbiota-Orientated Treatments for Major Depression and Schizophrenia. Nutrients. 2020; 12(4):1024.

Chicago/Turabian Style

Fond, Guillaume B., Jean-Christophe Lagier, Stéphane Honore, Christophe Lancon, Théo Korchia, Pierre-Louis Sunhary De Verville, Pierre-Michel Llorca, Pascal Auquier, Eric Guedj, and Laurent Boyer. 2020. "Microbiota-Orientated Treatments for Major Depression and Schizophrenia" Nutrients 12, no. 4: 1024.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop